Back to
TD Waterhouse Canada Inc.
BCTX5 quarters
Position history for
TD Waterhouse Canada Inc.'s holdings in BRIACELL THERAPEUTICS CORP
Yes. TD Waterhouse Canada holds 19 shares of BCTX (Briacell Therapeutics), worth $78, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. TD Waterhouse Canada has held BCTX since Q3 2025, across 5 quarterly 13F filings.
Current Value
$78
Current Shares
19
Total Value Change
-$160
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of BCTX: UBS Group AG, CITADEL ADVISORS LLC, HRT FINANCIAL LP, JANE STREET GROUP, LLC